Mabtech AB is a privately owned Swedish biotech company founded in 1986. Mabtech develops, manufactures and markets high quality monoclonal antibodies and kits suited for ELISA, ELISpot and FluoroSpot. For many years we have been a world leader in the field of ELISpot due to our strong research focus and continuous effort to optimize this technique. Our close collaborations with both academia and industry around the globe pave the way for future developments that help the research community achieve results.
|
|
|
|
|
51-200 employees
View all Mabtech AB employees
|
|
|
Research Services
|
|
|
Augustendalstorget 9, Nacka Strand, Stockholm County 131 52, SE
|
|
|
1986
|
|
|
Elisa, Reader, Immunoassays, Elispot, Fluorospot, Monoclonal Antibodies, Csl, Spot Analysis
|
Kjell Ostrand is the CEO of Mabtech AB. To contact Kjell Ostrand email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.